Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-17

Study Completion Date

2025-11-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China

This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Translational Assessment of Vitiligo According to Body Locations

NCT06068218

Vitiligo

ACTIVE_NOT_RECRUITING NA

Investigating Healthcare Disparities in Vitiligo

NCT06097494

Vitiligo

COMPLETED

Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles

NCT07298551

Vitiligo

NOT_YET_RECRUITING

IL35 Level in Vitiligo

NCT05980390

IL35, Vitiligo

UNKNOWN

The Gut and Skin Microbiome in Vitiligo Disease Progression

NCT03577327

Vitiligo Healthy

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cross-Sectional

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Segmental Vitiligo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female patients, age ≥ 12.
* Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI\<50) with or without facial involvement.
* Medical history available within the last 6 months.
* Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and \< 18 years of age at inclusion visit).
* Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable.

Exclusion Criteria

* Unable or unwilling to comply with study requirements and electronic Patient-Reported Outcome (ePRO) collection.
* Segmental or localized vitiligo.
* Greater than 33% leukotrichia in areas of vitiligo on the face or on the body.
* History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo.
* Patients who are participating in interventional clinical trial(s) at time of study visit.
* Patients who are currently receiving treatment with any investigational drug/device/intervention or have received any investigational product within 1 month or 5 half-lives of the investigational agent (whichever is longer) prior to enrollment.

Minimum Eligible Age

12 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No